Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome

被引:48
作者
Beresford, MW [1 ]
Shaw, NJ [1 ]
机构
[1] Liverpool Womens Hosp, Neonatal Unit, Liverpool L8 7SS, Merseyside, England
关键词
D O I
10.1203/01.PDR.0000036626.67304.65
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pro-inflammatory cytokines such as IL-8 play an important role in the inflammatory response to neonatal airway injury. Difficulty in detecting counter-regulatory cytokines such as IL-10 in lavage fluid from preterm infants led to the suggestion that its deficit may be a factor in the etiology of chronic lung disease of prematurity (CLD). The aim of the study was to determine IL-8 and IL-10 concentrations in lavage fluid from preterm infants ventilated for respiratory distress syndrome. Fifty infants <30 wk gestation were studied who had been randomized to receive a natural or synthetic surfactant. Lavage samples were collected daily for the first week and twice weekly thereafter. Samples were immediately centrifuged and stored at -70degreesC. Cytokine concentrations were quantified in duplicate using commercially available sandwich ELISA kits. Lavage IL-10 concentration, at a minimum initially, rose significant over the first five postnatal days (p = 0.009). In the same samples, lavage IL-8 concentrations rose significantly over the first postnatal week (p < 0.001), the rise preceding that of IL-10. Infants dying or developing CLD had a significant early rise in both cytokine concentrations. Compared with infants developing CLD, lavage IL-10 concentrations were significantly higher on d 1 among those not developing CLD but significantly lower on d 4 (p < 0.05). To conclude, IL-10 is detectable in lavage fluid from ventilated preterm infants and its concentrations rise significantly over the first five postnatal days. In the same samples, IL-8 concentration also rises and this increase precedes the rise in IL-10.
引用
收藏
页码:973 / 978
页数:6
相关论文
共 28 条
[1]   Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial [J].
Ainsworth, SB ;
Beresford, MW ;
Milligan, DWA ;
Shaw, NJ ;
Matthews, JNS ;
Fenton, AC ;
Platt, MPW .
LANCET, 2000, 355 (9213) :1387-1392
[2]   PULMONARY INFLAMMATORY CELLS IN VENTILATED PRETERM INFANTS - EFFECT OF SURFACTANT TREATMENT [J].
ARNON, S ;
GRIGG, J ;
SILVERMAN, M .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1993, 69 (01) :44-48
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]   COMPARISON OF SURFACE-PROPERTIES AND PHYSIOLOGICAL-EFFECTS OF A SYNTHETIC AND A NATURAL SURFACTANT IN PRETERM RABBITS [J].
CORCORAN, JD ;
BERGGREN, P ;
SUN, B ;
HALLIDAY, HL ;
ROBERTSON, B ;
CURSTEDT, T .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1994, 71 (03) :F165-F169
[5]   The pulmonary surfactant system: Biochemical and clinical aspects [J].
Creuwels, LAJM ;
vanGolde, LMG ;
Haagsman, HP .
LUNG, 1997, 175 (01) :1-39
[6]   Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease [J].
Dargaville, PA ;
South, M ;
McDougall, PN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :771-777
[7]   Validity of markers of dilution in small volume lung lavage [J].
Dargaville, PA ;
South, M ;
Vervaart, P ;
McDougall, PN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (03) :778-784
[8]  
de Blic J, 2000, EUR RESPIR J, V15, P217
[9]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[10]   INFLAMMATORY MEDIATORS AND BRONCHOPULMONARY DYSPLASIA [J].
GRONECK, P ;
SPEER, CP .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1995, 73 (01) :F1-F3